TG
UTHR icon

TLP Group’s United Therapeutics UTHR Stock Holding History

TLP Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,900
Closed -$246K – 633
2017
Q2 		$246K Buy
+1,900
New +$237K 0.23% 157
2016
Q1 		– Sell
-1,985
Closed -$311K – 404
2015
Q4 		$311K Buy
+1,985
New +$289K 0.25% 96

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

TLP Group's UTHR Position: Q3 2017 in Review

TLP Group sold out of United Therapeutics (UTHR) in Q3 2017, closing a stake of 1,900 shares — an estimated $246K sold.

TLP Group first reported a position in UTHR in Q4 2015 and held it in 2 quarters. The position peaked at $311K in Q4 2015. 373 funds tracked by Wall St. Rank hold UTHR as of Q3 2017.

  • TLP Group reported no remaining United Therapeutics position as of Q3 2017 after selling out during the quarter.
  • TLP Group sold 1,900 United Therapeutics shares in Q3 2017, an estimated $246K.
  • TLP Group first reported a position in United Therapeutics in Q4 2015 and held it in 2 quarters.
  • TLP Group's United Therapeutics position peaked at $311K in Q4 2015.
  • 373 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2017.

Based on TLP Group's 13F filing for Q3 2017, filed 14 Nov 2017.